Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

The use of nonsteroidal anti-inflammatory drugs (NSAIDs): A Science Advisory from the American Heart Association

  • Joel S. Bennett
  • , Alan Daugherty
  • , David Herrington
  • , Philip Greenland
  • , Harold Roberts
  • , Kathryn A. Taubert

Producción científica: Articlerevisión exhaustiva

79 Citas (Scopus)

Resumen

Current evidence indicates that selective COX-2 inhibitors have important adverse cardiovascular effects including increased risk for myocardial infarction, stroke, heart failure, and hypertension. The risk for these adverse effects are likely greatest in patients with a prior history of, or at high risk for cardiovascular disease. In these patients, use of COX-2 inhibitors for pain relief should be limited to patients for whom there are no appropriate alternatives; and then, only in the lowest dose and for the shortest duration necessary. More long-term data are needed to fully evaluate the extent to which these important adverse cardiovascular effects may be offset by other beneficial effects of these medications. More data are also needed concerning the cardiovascular safety of conventional NSAIDs. Until such data are available, the use of any COX inhibitor, including over-the-counter NSAIDs, for long periods of time should only be considered in consultation with a physician.

Idioma originalEnglish
Páginas (desde-hasta)1713-1716
Número de páginas4
PublicaciónCirculation
Volumen111
N.º13
DOI
EstadoPublished - abr 5 2005

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

  1. Good health and well being
    Good health and well being

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Huella

Profundice en los temas de investigación de 'The use of nonsteroidal anti-inflammatory drugs (NSAIDs): A Science Advisory from the American Heart Association'. En conjunto forman una huella única.

Citar esto